Cargando…

In vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application

BACKGROUND: Graphene is considered as a wonder material; it is the strongest material on the planet, super-elastic, and conductive. Its application in biomedicine is huge, with a multibillion-dollar industry, and will revolutionize the diagnostic and treatment of diseases. However, its safety and po...

Descripción completa

Detalles Bibliográficos
Autores principales: Amrollahi-Sharifabadi, Mohammad, Koohi, Mohammad Kazem, Zayerzadeh, Ehsan, Hablolvarid, Mohammad Hassan, Hassan, Jalal, Seifalian, Alexander M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110298/
https://www.ncbi.nlm.nih.gov/pubmed/30174424
http://dx.doi.org/10.2147/IJN.S168731
_version_ 1783350454271344640
author Amrollahi-Sharifabadi, Mohammad
Koohi, Mohammad Kazem
Zayerzadeh, Ehsan
Hablolvarid, Mohammad Hassan
Hassan, Jalal
Seifalian, Alexander M
author_facet Amrollahi-Sharifabadi, Mohammad
Koohi, Mohammad Kazem
Zayerzadeh, Ehsan
Hablolvarid, Mohammad Hassan
Hassan, Jalal
Seifalian, Alexander M
author_sort Amrollahi-Sharifabadi, Mohammad
collection PubMed
description BACKGROUND: Graphene is considered as a wonder material; it is the strongest material on the planet, super-elastic, and conductive. Its application in biomedicine is huge, with a multibillion-dollar industry, and will revolutionize the diagnostic and treatment of diseases. However, its safety and potential toxicity is the main challenge. METHODS: This study assessed the potential toxicity of graphene oxide nanoplatelets (GONs) in an in vivo animal model using systemic, hematological, biochemical, and histopathological examinations. Normal saline (control group) or GONs (3–6 layers, lateral dimension=5–10 μm, and thickness=0.8–2 nm) at dose rate of 50, 150, or 500 mg/kg were intraperitoneally injected into adult male Wistar rats (n=5) every 48 hours during 1 week to receive each animal a total of four doses. The animals were allowed 2 weeks to recover after the last dosing. Then, animals were killed and the blood was collected for hematological and biochemical analysis. The organs including the liver, kidney, spleen, lung, intestine, brain, and heart were harvested for histopathological evaluations. RESULTS: The results showed GONs prevented body weight gain in animals after 21 days, treated at 500 mg/kg, but not in the animals treated at 150 or 50 mg/kg GONs. The biochemical analysis showed a significant increase in total bilirubin, with a significant decrease in triglycerides and high-density lipoprotein in animals treated at 500 mg/kg. Nonetheless, other hematological and biochemical parameters remained statistically insignificant in all GONs treated animals. The most common histopathological findings in the visceral organs were granulomatous reaction with giant cell formation and accumulation of GONs in capsular regions. Also, small foci of neuronal degeneration and necrosis were the most outstanding findings in the brain, including the cerebellum. CONCLUSION: In conclusion, this study shows that GONs without functionalization are toxic. The future study is a comparison of the functionalized with non-functionalized GONs.
format Online
Article
Text
id pubmed-6110298
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61102982018-08-31 In vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application Amrollahi-Sharifabadi, Mohammad Koohi, Mohammad Kazem Zayerzadeh, Ehsan Hablolvarid, Mohammad Hassan Hassan, Jalal Seifalian, Alexander M Int J Nanomedicine Original Research BACKGROUND: Graphene is considered as a wonder material; it is the strongest material on the planet, super-elastic, and conductive. Its application in biomedicine is huge, with a multibillion-dollar industry, and will revolutionize the diagnostic and treatment of diseases. However, its safety and potential toxicity is the main challenge. METHODS: This study assessed the potential toxicity of graphene oxide nanoplatelets (GONs) in an in vivo animal model using systemic, hematological, biochemical, and histopathological examinations. Normal saline (control group) or GONs (3–6 layers, lateral dimension=5–10 μm, and thickness=0.8–2 nm) at dose rate of 50, 150, or 500 mg/kg were intraperitoneally injected into adult male Wistar rats (n=5) every 48 hours during 1 week to receive each animal a total of four doses. The animals were allowed 2 weeks to recover after the last dosing. Then, animals were killed and the blood was collected for hematological and biochemical analysis. The organs including the liver, kidney, spleen, lung, intestine, brain, and heart were harvested for histopathological evaluations. RESULTS: The results showed GONs prevented body weight gain in animals after 21 days, treated at 500 mg/kg, but not in the animals treated at 150 or 50 mg/kg GONs. The biochemical analysis showed a significant increase in total bilirubin, with a significant decrease in triglycerides and high-density lipoprotein in animals treated at 500 mg/kg. Nonetheless, other hematological and biochemical parameters remained statistically insignificant in all GONs treated animals. The most common histopathological findings in the visceral organs were granulomatous reaction with giant cell formation and accumulation of GONs in capsular regions. Also, small foci of neuronal degeneration and necrosis were the most outstanding findings in the brain, including the cerebellum. CONCLUSION: In conclusion, this study shows that GONs without functionalization are toxic. The future study is a comparison of the functionalized with non-functionalized GONs. Dove Medical Press 2018-08-22 /pmc/articles/PMC6110298/ /pubmed/30174424 http://dx.doi.org/10.2147/IJN.S168731 Text en © 2018 Amrollahi-Sharifabadi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Amrollahi-Sharifabadi, Mohammad
Koohi, Mohammad Kazem
Zayerzadeh, Ehsan
Hablolvarid, Mohammad Hassan
Hassan, Jalal
Seifalian, Alexander M
In vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application
title In vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application
title_full In vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application
title_fullStr In vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application
title_full_unstemmed In vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application
title_short In vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application
title_sort in vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110298/
https://www.ncbi.nlm.nih.gov/pubmed/30174424
http://dx.doi.org/10.2147/IJN.S168731
work_keys_str_mv AT amrollahisharifabadimohammad invivotoxicologicalevaluationofgrapheneoxidenanoplateletsforclinicalapplication
AT koohimohammadkazem invivotoxicologicalevaluationofgrapheneoxidenanoplateletsforclinicalapplication
AT zayerzadehehsan invivotoxicologicalevaluationofgrapheneoxidenanoplateletsforclinicalapplication
AT hablolvaridmohammadhassan invivotoxicologicalevaluationofgrapheneoxidenanoplateletsforclinicalapplication
AT hassanjalal invivotoxicologicalevaluationofgrapheneoxidenanoplateletsforclinicalapplication
AT seifalianalexanderm invivotoxicologicalevaluationofgrapheneoxidenanoplateletsforclinicalapplication